Association of dimethylarginines and mediators of inflammation after acute ischemic stroke

[1] Nishiyama Y(2010)Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke J Neurol Sci 290 12-15

[2] Ueda M(2009)Intima-media thickness and flow-mediated vasodilation in asymptomatic subjects with newly detected severe hypercholesterolemia Echocardiography 26 1060-1068

[3] Katsura KI(2006)Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population Atherosclerosis 185 271-277

[4] Otsuka T(2009)Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity Neurochem Res 34 1642-1649

[5] Abe A(2010)Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke Atherosclerosis 208 518-523

[6] Nagayama H(2011)High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke J Atheroscler Thromb 18 753-761

[7] Katayama Y(2006)The harms and benefits of inflammatory and immune responses in vascular disease Stroke 37 291-293

[8] Vladimirova-Kitova L(2011)Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood–brain barrier damage and brain oedema independently of infarct size J Neuroinflammation 8 164-528

[9] Terzieva D(2010)The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia J Neuroinflammation 7 74-51

[10] Marinov B(2007)Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells Am J Respir Cell Mol Biol 36 520-170

[1] Nishiyama Y(2010)Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke J Neurol Sci 290 12-15

[2] Ueda M(2009)Intima-media thickness and flow-mediated vasodilation in asymptomatic subjects with newly detected severe hypercholesterolemia Echocardiography 26 1060-1068

[3] Katsura KI(2006)Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population Atherosclerosis 185 271-277

[4] Otsuka T(2009)Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity Neurochem Res 34 1642-1649

[5] Abe A(2010)Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke Atherosclerosis 208 518-523

[6] Nagayama H(2011)High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke J Atheroscler Thromb 18 753-761

[7] Katayama Y(2006)The harms and benefits of inflammatory and immune responses in vascular disease Stroke 37 291-293

[8] Vladimirova-Kitova L(2011)Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood–brain barrier damage and brain oedema independently of infarct size J Neuroinflammation 8 164-528

[9] Terzieva D(2010)The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia J Neuroinflammation 7 74-51

[10] Marinov B(2007)Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells Am J Respir Cell Mol Biol 36 520-170